Romain S, Spyratos F, Lainé-Bidron C, Bouchet C, Guirou O, Martin P M, Oglobine J, Magdelénat H
Laboratoire d'Oncologie Biologique-Biopathologie Tissulaire, Faculté de Médecine Nord, Marseille, France.
Eur J Clin Chem Clin Biochem. 1995 Sep;33(9):603-8.
The urokinase type plasminogen activator (u-PA) and the plasminogen activator inhibitor-1 (PAI-1) are among the best second-generation prognostic tissue factors in breast cancer. However, different extraction procedures and assay kits are used in different laboratories. A total of 79 breast tumour tissues stored in liquid nitrogen were analysed in this study. We compared u-PA and PAI-1 levels determined with the American Diagnostics (AD) kit after various extraction procedures. The median cytosolic extraction yield in the presence of 0.4 mol/l KCl, calculated relative to extraction in the presence of 10 ml/l Triton X100 when adapted to standard laboratory working hours (incubation for 2 h instead of 12 h) was 74.4% for u-PA and 85.8% for PAI-1. In addition, the correlations were acceptable. Cytosolic extracts prepared with KCl could permit optimal u-PA and PAI-1 assays while also enabling hormone receptors to be determined with the same specimens. Further studies with clinical data are now necessary to determine the prognostic relevance of this extraction procedure.
尿激酶型纤溶酶原激活剂(u-PA)和纤溶酶原激活剂抑制剂-1(PAI-1)是乳腺癌中最佳的第二代预后组织因子。然而,不同实验室使用不同的提取程序和检测试剂盒。本研究分析了79份储存在液氮中的乳腺肿瘤组织。我们比较了在各种提取程序后用美国诊断公司(AD)试剂盒测定的u-PA和PAI-1水平。当适应标准实验室工作时间(孵育2小时而非12小时)时,相对于在10 ml/l Triton X100存在下的提取,在0.4 mol/l KCl存在下的细胞质提取产率中位数,u-PA为74.4%,PAI-1为85.8%。此外,相关性是可接受的。用KCl制备的细胞质提取物可允许进行最佳的u-PA和PAI-1检测,同时还能使用相同标本测定激素受体。现在需要进一步结合临床数据进行研究,以确定这种提取程序的预后相关性。